Note 5 – Income Taxes
As of March 31, 2017, the Company had net operating loss carry forwards of $1,413,662 that may be available to reduce future years’ taxable income in varying amounts through 2036. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards.
The approximate cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax asset amount is as follows as of March 31, 2017, March 31, 2016 and February 29, 2016:
| |
March 31,
|
|
March 31,
|
|
February 29,
|
|
| |
2017
|
|
2016
|
|
2016
|
|
|
Federal income tax benefit attributable to:
|
|
|
|
|
|
|
|
Current Operations
|
|
$
|
480,645
|
|
|
$
|
307,004
|
|
|
$
|
295,500
|
|
|
Less: valuation allowance
|
|
|
(480,645
|
)
|
|
|
(307,004
|
)
|
|
|
(295,500
|
)
|
|
Net provision for Federal income taxes
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
The net change in the total valuation allowance for the years ended March 31, 2017 and February 29, 2016 were $173,641 and $116,546, respectively. The net change in the total valuation allowance for one month ended March 31, 2016 was $11,504.